The memory T cell immune response to Mycobacterium tuberculosis infection was examined in strains of mice which vary in their natural susceptibility to Mycobacterium bovis BCG infection. Naturally susceptible (NS) C57BL/6 and naturally resistant (NR) B6D2 F1 hybrid mice were infected with a sublethal dose of M. tuberculosis and then given antibiotic therapy beginning 2 weeks postinfection. T cells from both strains of mice transferred significant levels of resistance to syngeneic mice challenged aerogenically with M. tuberculosis. This memory response was not substantially reduced by depletion of either L3T4+ or Lyt2+ T cells from the donor mice but was ablated by depletion of both T cell subsets. Cyclophosphamide pretreatment of C57BL/6 memory T cell donors also ablated the resistance transferred to recipient mice. In contrast, B6D2 memory T cells were not affected by cyclophosphamide treatment, suggesting that differences may exist in the metabolic state of the memory T cells in the two donor strains, despite the fact that they both develop similar levels of acquired resistance to a subsequent tuberculous challenge.
Inbred mouse strains have been designated as naturally susceptible (NS) or naturally resistant (NR) on the basis of the growth patterns of Mycobacterium bovis BCG seen in the spleens of minimally infected mice (5) . The list of mouse strains which fit these two categories has been expanded to include infections with various mycobacterial species (1) . Analysis of the innate immune response to BCG infection in the NR mice suggested that the poor response was largely due to limited growth in the spleen by the immunizing agent (14) . On the other hand, Mycobacterium tuberculosis showed similar growth patterns in both NS and NR mice (18) , and the resulting T cell-mediated resistance was crossprotective against infections caused by other mycobacterial species, regardless of the genetic background of the mouse strain (15, 16) . In addition, such mycobacterial infections have been shown to nonspecifically activate macrophages which express enhanced tumoricidal, leishmanicidal, and bactericidal activities against a number of unrelated organisms (11, 19) .
Development of a persistent memory immune response must be the goal of any rational immunization procedure. The presence of such cells in tuberculous mice can be demonstrated by means of prolonged antibiotic therapy, which eliminates the stimulating infection from the tissues without affecting the ability of the splenic T cells to protect the host against reinfection (15) . Most of these experiments have been carried out in B6D2 (NR) mice, and relatively little is known about the ability of NS mice to generate a memory T cell immune response against a virulent M. tuberculosis infection. Thus, the purpose of the present study was to compare the development of memory T cellmediated immunity in NR versus that in NS mice after a sublethal M. tuberculosis infection. The phenotype (L3T4+ or Lyt2+) and the cyclophosphamide (CY) sensitivity of the T cells harvested from both mouse strains and the effect of depletion of L3T4+ or Lyt2+ T cells on the memory immune response were compared in susceptible versus resistant mouse strains and were shown to vary substantially. * Corresponding author.
MATERIALS AND METHODS
Mice. Six-to 8-week-old male C57BL/6 (NS) and (C57BL/6 x DBA/2)F1 hybrid (NR) B6D2 mice were obtained from the Trudeau Institute Animal Breeding Facility, Saranac Lake, N.Y. These mouse strains vary genetically at several loci, including those for innate resistance and H-2 haplotype. The mice were raised under barrier conditions and given sterilized food and acidified water ad libitum (12) .
Organisms. M. tuberculosis Erdman was obtained from the Trudeau Mycobacterial Collection, Saranac Lake, N.Y. The organisms were grown and stored at -70°C as previously described (2) . The (15) . Memory T cells were harvested from donor animals 1 month after completion of the antibiotic treatment.
Adoptive transfer of acquired resistance by using splenic T cells. Single-cell suspensions were prepared from the spleens of donor mice by pressing the tissue through a stainless steel screen into RPMI 1640 medium (GIBCO, Grand Island, N.Y.) containing 10% heat-inactivated fetal calf serum (GIBCO), 1 mM sodium pyruvate, 2 mM L-glutamine, 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), and 5 x 10-5 M 2-mercaptoethanol but not containing antibiotics (12) . The cell suspensions were enriched for T cells by a double adherence protocol. To remove the macrophages, 20-ml aliquots of the cell suspension (107 cells per ml) were incubated for 45 min at 37°C in 10% C02-enriched air on tissue culture dishes (150 by 25 mm; Falcon) which had been coated with the antimacrophage monoclonal antibodies F4/80 and Mac-1 (13) . Nonadherent cells were removed by gentle rinsing with fresh medium and were incubated for 30 min at 37°C on plates coated with 20 ,ug of goat anti-mouse immunoglobulin G (Cappel Laboratories, Cochranville, Pa.) per ml to allow the adherence of immunoglobulin-bearing cells. The T cell-enriched nonadherent cells were rinsed off, washed in cold complete medium, resuspended in 0.01 M phosphate-buffered saline containing 1% fetal calf serum, and standardized to a concentration of 2 x 107 viable cells per ml (15) .
The splenic T cells were infused into sublethally irradiated (500 rads of gamma radiation given 24 h earlier) syngeneic recipient mice at a one-spleen equivalent dose. In some experiments, antibiotic-treated donor mice were also pretreated with 150 mg of CY (Cytoxan; Mead-Johnson, Evansville, Ill.) per kg of body weight by intraperitoneal injection 1 day prior to the transfer (10). Other mice were pretreated intravenously with 500 jig of anti-L3T4 (GK1.5) and/or anti-Lyt2 (TIB 210) monoclonal antibodies 1 day prior to transfer. In vivo T cell subset depletion by this method was preferred because it utilized the mouse's complement system to lyse the relevant antigen-bearing T cell subsets prior to each transfer. Recipient mice were challenged intravenously 1 day later with 105 CFU of M. tuberculosis. A fluorescence-activated cell sorter (FACS) was used to analyze the T cell subsets present in the recipient mice 2 days after the T cell transfer to confirm the depletion of the appropriate T cell subsets (9) .
Delayed-type hypersensitivity (DTH). M. tuberculosis-infected mice were injected in the left hind footpad with 0.025 ml of saline containing 10 ,g of purified protein derivative (PPD) (Evans Medical Ltd., Langhurst, England). Saline alone was injected into the contralateral footpad, and the footpad thickness was (Fig. 1) . Logarithmic growth of the inoculum occurred in the spleens of mice of both strains during the first 2 weeks of the infection, and in C57BL/6 mice, this was followed by a decline in the number of viable bacilli recovered from the spleens over the next 6 weeks of infection. The number of organisms in the spleens of B6D2 mice continued to increase for 2 weeks further before beginning a gradual decline. The infection increased in the lungs of both mouse strains over the entire 8-week period. Both strains of mice developed substantial tuberculin reactivity (4 weeks), but this reactivity had declined to nonsignificant levels by 8 weeks (Fig. 1) .
Groups of C57BL/6 and B6D2 mice which had been infected 8 weeks previously were used as donors of "immune" T cells, which were infused into irradiated syngeneic recipients. Control mice were infused with an equivalent number of normal T cells. Acquired resistance was measured as a reduction in the growth of M. tuberculosis in the recipients of immune T cells compared with growth in recipients of normal T cells (it should be noted that the infection develops more rapidly in the irradiated mice). The recipients of immune T cells from either test strain showed substantial resistance 2 weeks postinfection (Fig. 1) . The cells also transferred a barely significant level of tuberculin hypersensitivity to the recipient host, measured 1 week postinfection, compared with the recipients of normal T cells.
Transfer of acquired resistance to M. tuberculosis by memory T cells. Equal numbers of T cells were transferred from both mouse strains after a 6-week regimen of antibiotic therapy which effectively eliminated the immunizing infection ( Fig. 2 and 3 ). Memory T cells acquired from the spleens of these treated donor mice were transferred into syngeneic irradiated recipients, and they induced substantial protection against a fully virulent challenge given to both recipient mouse strains, compared with growth in the corresponding control mice (Fig. 2 and 3) . However, the memory immune T cells harvested from the C57BL/6 donors conferred less (though still significant) acquired resistance to the recipient mice (Fig. 2) than the B6D2 memory T cells did (Fig. 3) . The resistance indices for the lungs were always significantly lower than those for the spleens at 4 weeks postinfection.
When the donors were pretreated with CY 1 day prior to the transfer, this resistance was completely ablated in the C57BL/6 recipients ( Fig. 2) but not in the B6D2 mice (Fig. 3) . The effect of CY treatment of the C57BL/6 mice was shown to be dose dependent, but even the highest dose of CY was unable to ablate the memory T cell response in the B6D2 mice (Table 1) Transfer of tuberculin hypersensitivity by memory immune T cells from both B6D2 and C57BL/6 mice was also highly susceptible to CY treatment ( Fig. 2 and 3) . Treatment of immune donor mice with CY ablated the ability of the recipient mice to elicit a DTH response to PPD, whereas the recipients of untreated memory immune T cells exhibited a significant level of tuberculin hypersensitivity 1 week posttransfer.
Effect ofT cell subset depletion on the transfer of immunity. The phenotype of the memory T cells was determined by in vivo depletion of L3T4+ and/or Lyt2+ T cell subsets in the donor mice prior to the transfer of T cells into syngeneic recipients. There was no substantial reduction exhibited in the level of acquired resistance after depletion of either T cell subset (Table 2) . However, when the donor mice were treated with both anti-L3T4 and anti-Lyt2 antibodies, resistance was reduced to near control levels. A FACS analysis carried out on the T cell populations in the recipient mice 2 days after the adoptive transfer indicated a 90 to 95% depletion of L3T4+ T cells and a 89 to 94% depletion of the Lyt2+ T cell subsets, compared with amounts in undepleted immune recipients ( Table 2 ). Depletion of both L3T4+ and Lyt2+ T cells markedly reduced the number of Thyl.2+ cells detected in recipient mice (87% depletion), whereas recipients of control cells showed a normal distribution of T cell subsets (data not shown).
T cell depletion also affected the ability of the recipient mice to express a tuberculin response. The DTH response in the recipient mice was substantially reduced by depletion of L3T4+ T cells in the immune donor before transfer to the recipient animals (Table 3) . On the other hand, depletion of donor Lyt2+ cells slightly enhanced the DTH response seen in the B6D2 mice ( Table 3) . As expected, treatment of the donor mice with both anti-L3T4 and anti-Lyt2 antibodies eliminated the ability of the recipient mice to express tuberculin responsiveness (Table 3) .
DISCUSSION
The present study indicates that both C57BL/6 and B6D2 mice are capable of developing memory T cell populations able to mediate effective antituberculous resistance to a subsequent virulent challenge. Thus, when memory immune T cells were transferred to naive syngeneic recipients, both test groups resisted the rapid growth of the M. tuberculosis challenge which normally would lead to the death of nonimmune animals. The difference in growth of M. tuberculosis in recipients infused with immune versus normal T cells was especially evident during the first 2 weeks of the infection ( Fig. 2 and 3 ). Of particular interest was the finding that the innately susceptible C57BL/6 mice were still able to generate a memory T cell population which effectively stopped the growth of the virulent challenge in a manner little different from that of the B6D2 mice. Thus, the innate susceptibility of the C57BL/6 mice to BCG infection (6) does not negate the ability of this host to develop a protective memory immune response against M. tuberculosis, provided that the host is appropriately vaccinated. The genetic differences at the Bcg gene locus, which segregates the mouse strains into NR and NS categories, were based on early proliferation of BCG in the tissues, which in turn depends upon the ability of the macrophages to limit the growth of the intracellular mycobacteria (1). These macrophage functions also appear to be important in the expression of resistance to other acute infections caused by rapidly proliferating intracellular organisms such as salmonellae or listeriae (17, 18) . Although the infected macrophage is ultimately the effector cell in the innate immune response to M. tuberculosis infection, this response requires a T cell-mediated response in order to fully protect the host (4). This is also true for the memory cell response, which has been clearly shown to depend on T cells bearing the Thyl.2 surface marker (10) . The present study indicates that both L3T4+ and Lyt2+ T cells may be involved in this memory immune response, a finding which is consistent with earlier data obtained with M. tuberculosis-infected CBA and B6D2 (NR) mice (8, 9) , and indicates a role for L3T4+ and Lyt2+ T cells in protection against virulent challenge. Recently, Orme reported that memory T cells which were generated in B6D2 mice in response to an M. tuberculosis infection were L3T4+ and that the Lyt2+ T cells were not capable of transferring resistance to irradiated recipient mice (11) . This difference from the present results (which show that both T cell subsets were involved in the expression of memory) may be due to technical differences in the methodologies, such as the length and type of the chemotherapy (42 versus 90 days and isoniazid combined with rifampin versus isoniazid alone), as well as the time interval between infusion of the recipient mice and the challenge (1 day versus 1 h) and the mode of T cell subset depletion (in vivo versus in vitro monoclonal antibody treatment). However, depletion of Thyl.2+ T cells (11) and depletion of both L3T4+ and Lyt2+ T cells (Fig. 2 and 3 ) both ablated the ability of these cells to transfer T cell-mediated memory immunity.
Immune T cells harvested from both B6D2 and C57BL/6 mice transferred similar levels of tuberculin hypersensitivity to the recipient mice, a finding which is in contrast to previous reports that only the innately susceptible mice developed tuberculin responsiveness following infection with BCG (6) . This difference may be due to the use of a virulent strain which resulted in substantial growth in the spleens of mice of both strains (Fig. 1) . This hypersensitivity was ablated by CY treatment of the donor mice ( Fig. 2 and  3) , suggesting that the T cells responsible for this response (L3T4+ [Table 3 ]) were different from those transferring memory T cell immunity (13, 20) . The fact that CY treatment of the immune mice had different effects on the memory T cell populations in the two mouse strains was unexpected ( Fig. 2 and 3 ) and may indicate that the memory response in the C57BL/6 mice does not enter a quiescent state (21) , possibly because of the presence of a nidus of infection (or bacterial products) in the innately susceptible strain which serves as a T cell-stimulatory antigen long after the antibiotic treatment has apparently eliminated the infection (7) . Another possibility is that the C57BL/6 mice are more susceptible to the toxic action of CY than are the more tolerant B6D2 mice (Table 1) . Further evaluation of the memory T cell populations in these genetically distinct mouse strains in terms of their relative resistance to CY cytotoxicity would seem to be appropriate. 
